Beruflich Dokumente
Kultur Dokumente
D-Cycloserine (DCS)
D-Cycloserine (DCS)
Cognitive Enhancement
Acute dosing: Single doses or weekly doses of 50-250 mg.
Anti-inflammatory (Neuroinflammation)
Chronic Dosing: Daily treatment of 50-100 mg for a month.
Neuroinflammatio
n
Measured by the
presence of proinflammatory
cytokines (CRP,
TNF, IL-1)
Cognitive
Symptoms
Diminished
short-term
memory, poor
attention,
worsened mood
Study Design
Main Intervention:
DCS medication, self-administration
100 mg daily for one month
2 groups of subjects:
Experimental Group: DCS Medication
Control Group: Placebo
Assessments:
GWI symptoms, neuropsychological test performance, mood,
sleep, quality of life.
Goals:
Timeline of Study:
6 visits over about two months.
Visits starting in June 2016.
Thank you!